Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
about
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductaseImpaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiencyThe molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersWhy boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiationPharmacogenomics of human P450 oxidoreductaseBackdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex developmentEffects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitroInfluence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6Regulation of P450 oxidoreductase by gonadotropins in rat ovary and its effect on estrogen productionRNA interference of NADPH-cytochrome P450 reductase results in reduced insecticide resistance in the bed bug, Cimex lectulariusNADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro systemMolecular Cloning, Expression Pattern and Polymorphisms of NADPH-Cytochrome P450 Reductase in the Bird Cherry-Oat Aphid Rhopalosiphum padi (L.).Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiencySilencing NADPH-cytochrome P450 reductase results in reduced acaricide resistance in Tetranychus cinnabarinus (Boisduval)Consequences of POR mutations and polymorphisms.Isolation and Expression Analysis of CYP9A11 and Cytochrome P450 Reductase Gene in the Beet Armyworm (Lepidoptera: Noctuidae).Functional characterization of NADPH-cytochrome P450 reductase from Bactrocera dorsalis: Possible involvement in susceptibility to malathion.Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiencyPrenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency.Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.Microsomal cytochrome P450 as a target for drug discovery and repurposing.Modeling of Anopheles minimus Mosquito NADPH-cytochrome P450 oxidoreductase (CYPOR) and mutagenesis analysis.Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria.Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.Cloning and characterisation of NADPH-dependent cytochrome P450 reductase gene in the cotton bollworm, Helicoverpa armigera.Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function.Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report.Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population
P2860
Q24607331-4A14936A-0A64-45F2-8C8B-B6E57DD837C4Q24609157-62F3EFF0-F31F-4FB0-8B4D-D8C819F6396DQ24613957-7A5C9562-2772-4EEF-BC69-512C0372C834Q24618043-FE9184F9-E743-4A0F-A043-16DB2C91CA99Q26998463-95617D64-F388-452E-B83F-13AF9D61C152Q28277259-52F85510-98CF-459D-BB06-21F23499471BQ28295439-9435D31E-D794-4EDF-B3D3-F322183C0500Q28484196-BCE9B0BA-066B-4BBA-903A-E0856117E2ACQ28566057-08A68EEE-8452-4986-9F93-9485DF72EAD5Q28732212-E2E630D3-348A-4EDF-A364-AAE5FF81AD02Q30537968-9790C293-C0DD-47D3-ACDA-D7F407C22F7EQ33431427-37C96DDB-9D60-4249-8F99-4769698839EAQ35046889-E2D98606-D477-4C8D-878B-6DA78A8E7818Q35846903-A9EC3D4F-773C-46F6-A094-B0CF31B95D53Q36001940-97D194B3-986F-4F72-A235-4EB393A06080Q36049127-9D67FE4E-3F61-4DF9-B022-C0FD24FCA9A2Q36192608-E059C696-0FFB-4450-AA4F-8836DD208859Q36248030-6D158BB0-D89E-4B71-8EB9-947D985E9D26Q36353293-F86791A6-60E2-412D-AF0A-D6279384DBE3Q36382390-40197535-D780-4DC7-9B33-973BA6E9A996Q36446526-779485B9-B757-4DDE-8F37-D4B42CFDFB2DQ36497649-F43901BF-B25B-4188-B734-2AE4E734B006Q36755276-E73406D3-B15E-4E32-9561-BE0C4B9630EFQ37001487-DB2B7619-7457-443F-BABC-C9C822D1A591Q37072683-E8BF5287-F03C-43BA-BC5C-E050833E9652Q37482676-002AF3D5-ACBF-47FB-A2C5-9D5063C6EC7CQ39000644-45FE1B65-6190-48DB-BA4F-B05A8DE4E9F4Q39431012-81652588-C6B8-4892-9C3F-B1785823293AQ41207020-D4368839-8843-4B82-B766-1E93EF44D034Q41808460-3893FED0-34B9-4F8E-83D1-58CEBE5514EBQ42009165-E4A77663-5BC3-4446-AAF6-637721922531Q42266862-D6BB263D-F8FC-4BDA-91A5-2C678CE54647Q43069462-3DCE4A4B-E2D8-44B0-BEEE-25ABEFC5F8DBQ47096419-15D26499-7BF2-4B30-A4AE-ABE2B540651DQ48607037-854E61BE-42E9-4D5A-BDFE-EBABFE53607AQ50083476-185ABCF7-23FC-409A-983F-4F7FED53E0EDQ55638445-E3AF0CEA-601F-4CF4-91C9-2958C076EF5AQ58581001-02BDA2C5-8A5E-43A7-9850-DB64396374CD
P2860
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@ast
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@en
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@nl
type
label
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@ast
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@en
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@nl
prefLabel
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@ast
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@en
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@nl
P2093
P3181
P356
P1476
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
@en
P2093
Christa E Flück
Gaby Hofer
Petra Kempná
Primus E Mullis
P304
P3181
P356
10.1210/ME.2007-0245
P407
P577
2007-10-01T00:00:00Z